New research has confirmed Ozempic reduces the risk of strokes and heart attacks by 20 percent - even in patients who weren't severely overweight to start with.
The study, which was led by University College London and published in The Lancet, found that weight loss accounted for only one third of this reduction.
Auckland University molecular medicine professor Peter Shepherd says this is proof other factors are behind the slowdown of heart disease.
"We know a few of them, we know a bit about how it effects heart tissue growth, we know a bit about the positive effects it has on the deposition of the lipids, but there's still a long way to go to fully understand its effects."
LISTEN ABOVE

Perspective with Heather du Plessis-Allan: The attention on the Waikato ED case could increase the odds of fixing the problem
02:06

Full Show Podcast: 03 July 2026
1:40:38

Perspective with Heather du Plessis-Allan: What real employer would do what the Ministry of Justice did?
02:25